SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Kirk Randal J, et al. – ‘SC 13D’ on 3/20/15 re: AmpliPhi Biosciences Corp – ‘EX-4’

On:  Friday, 3/20/15, at 4:21pm ET   ·   Accession #:  1140361-15-12832   ·   File #:  5-44887

Previous ‘SC 13D’:  ‘SC 13D/A’ on 2/10/15   ·   Next:  ‘SC 13D/A’ on 6/9/15   ·   Latest:  ‘SC 13D/A’ on 6/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/20/15  Kirk Randal J                     SC 13D                 2:168K AmpliPhi Biosciences Corp         Broadridge Fin’l So… Inc
          Intrexon Corp
          NRM VII Holdings I, LLC
          Third Security, LLC

General Statement of Beneficial Ownership   —   Sch. 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      Randal J Kirk SC 13D 3-16-2015 (Ampliphi            HTML     86K 
                          Biosciences Corp)                                      
 2: EX-4        Instrument Defining the Rights of Security Holders  HTML      8K 


EX-4   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 

Exhibit 4

Joint Filing Agreement

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of AmpliPhi Biosciences Corporation, and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 20th day of March, 2015.


 
 
     
 
THIRD SECURITY, LLC
     
     
 
By:
   
   
Manager
     
 
NRM VII HOLDINGS I, LLC
     
     
 
By:
   
   
Manager
     
 
INTREXON CORPORATION
     
     
 
By:
   
   
Chief Executive Officer




Top
Filing Submission 0001140361-15-012832   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 12:31:47.1am ET